Medication info

Rabisqu Di Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Tripotassium Bismuth Dicitrate›200mg / 1 tabletRanitidine Hydrochloride›168mg / 1 tabletSucralfate Hydrate›600mg / 1 tablet
Manufacturer / importer
Lite Pharm Tech Co., Ltd.
Appearance
Greenish elongated film-coated tablet
Packaging
10 tablets/bottle, 30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201905897 · Approved 2019.08.21

This product's status changed to Expired on 2024.08.21. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treats acid-related disorders (such as ulcers and reflux esophagitis) and prevents Mendelson syndrome
Who takes it
Adults
Adult dose
○ Adults Usually, take 1 tablet orally twice daily, in the morning and before bedtime, irrespective of meals. 1) Gastric and duodenal ulcers Take 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by taking 2 tablets twice daily, in the morning and before bedtime. The dose is the same for ulcers caused by administration of nonsteroidal anti-inflammatory drugs or for combination therapy to prevent gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Diseases caused by nonsteroidal anti-inflammatory drugs are usually cured within 4 weeks, and ulcers are usually cured within 8 weeks, although the healing period may sometimes be prolonged depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, take 1 tablet twice daily or 2 tablets once daily at bedtime. However, for patients with severe reflux esophagitis, the dose may be increased to 2 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 1 tablet 3 times daily as the initial dose, and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 1 tablet twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. In this case, it is preferable to also administer 1 tablet on the night before surgery.

Ingredients

Manufacturer
Lite Pharm Tech Co., Ltd.

Efficacy & effects

Treats acid-related disorders (such as ulcers and reflux esophagitis) and prevents Mendelson syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • reflux esophagitis
  • Mendelson syndrome
  • postoperative ulcers
View approved original text

This medication is used to treat gastrointestinal disorders, including ulcers of the stomach and duodenum, gastritis, Zollinger-Ellison syndrome, and reflux esophagitis. It also aids in the prevention of Mendelson syndrome before anesthesia and management of postoperative ulcers. It is effective in treating gastric and duodenal ulcers that may occur with the use of non-steroidal anti-inflammatory drugs (NSAIDs). This medication suppresses gastric acid secretion, alleviating symptoms and promoting recovery. Overall, it is useful for treating gastrointestinal-related disorders and improving symptoms.

How to take

Adult dose

○ Adults Usually, take 1 tablet orally twice daily, in the morning and before bedtime, irrespective of meals. 1) Gastric and duodenal ulcers Take 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by taking 2 tablets twice daily, in the morning and before bedtime. The dose is the same for ulcers caused by administration of nonsteroidal anti-inflammatory drugs or for combination therapy to prevent gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Diseases caused by nonsteroidal anti-inflammatory drugs are usually cured within 4 weeks, and ulcers are usually cured within 8 weeks, although the healing period may sometimes be prolonged depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, take 1 tablet twice daily or 2 tablets once daily at bedtime. However, for patients with severe reflux esophagitis, the dose may be increased to 2 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 1 tablet 3 times daily as the initial dose, and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 1 tablet twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. In this case, it is preferable to also administer 1 tablet on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis treatment or those with poor renal function. Additionally, patients who have had allergic reactions to this medication or its components should not take it. Patients with a history of acute porphyria, a rare blood disorder, should also avoid this medication. It should not be administered to patients who have undergone gastrointestinal surgery or to pregnant women or those who may become pregnant, as well as to premature infants and newborns. Patients on a potassium-restricted diet are also advised against using this medication. Patients with poor liver function, a history of drug allergies, elderly patients, and those with a history of kidney problems should exercise particular caution when using this medication. If taken in conjunction with non-steroidal anti-inflammatory drugs, regular monitoring is necessary, as this may mask symptoms of gastric cancer; therefore, gastric ulcer patients or those over middle age with newly emerging dyspeptic symptoms should be assessed for malignancy before administration. Patients with Helicobacter pylori infection and gastric/duodenal ulcers require eradication therapy. Care should be taken when using this medication in critically ill patients, those with hypophosphatemia, or those with swallowing difficulties. While taking this medication, adverse reactions such as allergic shock, skin rash, urticaria, and angioedema may rarely occur; should any abnormal symptoms arise, cease use immediately and consult with a healthcare professional. This medication may affect the blood, potentially reducing white blood cell or platelet counts, so if symptoms such as fatigue, bleeding, or fever appear, testing should be conducted. Liver dysfunction may occur; should jaundice or severe fatigue present, stop taking the medication. Reported symptoms such as abnormal heart rhythm, nausea, diarrhea, headache, dizziness, drowsiness, confusion, etc., warrant caution. If muscle pain or joint pain occurs, consult a doctor; it may also cause skin rash or hair loss. Long-term use of this medication is not recommended, and if no therapeutic effect is observed, switching to another medication is advised. Elderly patients or those with chronic lung disease, diabetes, or weakened immune systems should be cautious as they may have an increased risk of pneumonia. If experiencing dizziness or drowsiness during use, avoid driving or operating hazardous machinery. This medication may interact with other drugs; if currently taking any other medications, it's essential to inform your healthcare provider, especially when taking anticoagulants, antibiotics, or certain painkillers. It is safer for pregnant or breastfeeding women to avoid this medication. Safety has not been established for pediatric use, so administration to children is not recommended. In the case of overdose, vomiting or gastric lavage may be required; in severe cases, removal may be possible through hemodialysis. This medication reduces gastric acid secretion, which may promote bacterial growth in the stomach, so regular ophthalmic examinations are advised for long-term users.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 49 more
  • thrombocytopenia
  • elevated serum enzyme levels
  • agranulocytosis
  • pancytopenia
  • myelosuppression
  • aplastic anemia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • systemic fatigue
  • weakness
  • subcutaneous and mucosal hemorrhage
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal bloating
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • malaise
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disorders
  • galactorrhea
  • gynecomastia
  • hyperprolactinemia
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • skin itching
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a sealed container. It is best to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. This helps to preserve the effectiveness of the medication for an extended time.

Appearance and packaging

Appearance

Greenish elongated film-coated tablet

Package unit

10 tablets/bottle, 30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.